Navigation Links
Almac's Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection
Date:9/21/2010

de the way we build systems for our clients and manage the drugs that patients take during clinical trials. The MHRA inspection validates the quality procedures that Almac has put in place and offers another testimony to our focus on providing high quality technologies and services to biopharmaceutical companies worldwide. We typically excel at client audits and now have passed another key test - an MHRA inspection."

About Almac Group

The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 2,700 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Almac has officially gained full possession of its new $120m North American Headquarters which started in July 2008 and employees will relocate during the fall. .

Almac's Clinical Technologies division specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS(TM)) for patient randomization, tracking and clinical supply management, electronic-patient-reported- outcomes data collection, and Web drug reconciliation. Almac's technologies have been deployed in over 1500 clinical trials, incorporating over 1.5 million patients in over 80 countries, and more than 60 languages.

For more information about the Almac Group, please visit http://www.almacgroup.com or e-mail info@almacgroup.com.'/>"/>

SOURCE Almac Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014 Juno ... Breakthrough Therapy Designation to the company,s JCAR015 chimeric ... the treatment of relapsed or refractory B-cell acute ... partner, Memorial Sloan Kettering Cancer Center, where Phase ... "The FDA,s action is important news for ...
(Date:11/24/2014)... 24, 2014  Relmada Therapeutics, Inc. (OTCQB: RLMD), a ... chronic pain, announced today that Sergio Traversa , ... LD MICRO "MAIN Event" Micro-Cap Growth Conference on Wednesday, ... the Luxe Sunset Bel Air Hotel, which is located ... California . The presentation is scheduled ...
(Date:11/24/2014)... -- GlySens Incorporated announced today that it has been awarded ... Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), ... The grant is intended to support human clinical evaluation ... glucose monitoring system.  Final preparations for launch of the ... before the end of 2014. "We are ...
Breaking Medicine Technology:Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3Relmada Therapeutics To Present At LD MICRO Conference 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2
... Oct. 15 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... Annual NewsMakers in the Biotech Industry Conference on Friday, ... a.m. Eastern Time.  The session may be accessed through ... Investor Relations page.  An archived version of the presentation ...
... CINCINNATI, Oct. 15  "This is a significant decision in ... advocates and the entire pharmaceutical industry," commented Benjamin H. ... an en banc hearing was not necessary and that ... plaintiff,s claim that the diet drug Redux (commonly known ...
Cached Medicine Technology:
(Date:11/26/2014)... For those with a New Year’s resolution to ... classes at the University of Colorado Anschutz Health and ... for. The 45- 60 minute classes have just started and ... fitness club memberships. , LES MILLS BODYPUMP™ exercise classes strengthen, ... aimed at fast results , By focusing on low ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, Jennifer E. Hill, ... from The American Association of Nurse Practitioners ... nurse practitioners. The Distinguished Preceptorship Award recognizes the ... significant contribution toward increasing the awareness and acceptance ... (AANP) is the largest full-service national professional membership ...
(Date:11/26/2014)... (HealthDay News) -- Vultures have developed highly specialized ways ... eating dead animals, researchers report. The new research ... faces and in the guts of 50 turkey vultures ... the faces of the vultures had more than 500 ... guts, the study found. The findings suggest that ...
(Date:11/26/2014)... to peanut protein in household dust may increase the ... condition eczema, a new study reveals. About 2 ... allergic to peanuts. And severe eczema in infants has ... researchers noted. The new study included 359 infants ... the amount of peanut protein the children were exposed ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Parents need to take ... concussions, an expert warns. Parents must make sure ... standard, Dr. David Dodick, chair of the American Migraine ... Clinic College of Medicine in Scottsdale, Ariz. in an ... release. Any coach involved with teens sports needs ...
Breaking Medicine News(10 mins):Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2
... flow may be better conditioned to survive a full-blown ... University of Cincinnati (UC). , In a five-year ... when the heart experiences short periods of stress, either ... activates a protective molecular pathwayknown as JAK-STATthat protects the ...
... WuXi PharmaTech (NYSE:,WX), China,s premier provider of pharmaceutical R&D ... temporarily assume the role of,the Chairman of the Audit ... of the Audit Committee was previously held by Mr. ... his vacation., Mr. Cuong Viet Do has served ...
... drank more heavily than male peers, field study finds ... on-the-scene study of college drinking behavior shows that parties ... while themed parties encourage college women to drink more ... of college drinking have relied largely on individual behavior ...
... - President of cbm, Prof. Allen Foster,announces that cbm ... persons,with disability, not just persons with visual loss., ... Christoffel Blinden,Mission, and Christian Blind Mission, has worked to ... for persons,with visual loss., "The organization has decided ...
... 4 Health Secretary Dr.,Calvin B. Johnson today invited ... exhibit at the Farm Show for free health,screenings, fun ... Body Shop is a fun place for kids and ... running in peak condition," Dr. Johnson said.,"Everyone should stop ...
... International,Associates, Inc, administrator for the HealthShares(TM) Indexes, a ... Funds, today,announced that effective at the opening of ... ARQL ) will replace Coley Pharmaceutical, Inc.,(Nasdaq: ... Index. Coley,Pharmaceutical is being acquired by Pfizer, Inc. ...
Cached Medicine News:Health News:Mini 'stress tests' could help condition heart to survive major attack 2Health News:WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit Committee 2Health News:College Drinking Games Lead to Higher Blood Alcohol Levels 2Health News:cbm Expanding its Mandate 2Health News:QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index 2
The new CR6-45NM non-mydriatic retinal camera is an ideal diagnostic tool for ophthalmologists, optometrists and other medical professionals, especially when it comes to detecting and monitoring diab...
An ideal choice for film photography. The new TRC-50FXC provides 35mm color and Polaroid capability....
Digital imaging for optical screening: Diabetes, glaucoma macular degeneration, and other retinal disease....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
Medicine Products: